Cargando…
Use of FLOSEAL® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy
Induced neural stem cells (iNSCs) have emerged as a promising therapeutic platform for glioblastoma (GBM). iNSCs have the innate ability to home to tumor foci, making them ideal carriers for antitumor payloads. However, the in vivo persistence of iNSCs limits their therapeutic potential. We hypothes...
Autores principales: | Bomba, Hunter N., Carey‐Ewend, Abigail, Sheets, Kevin T., Valdivia, Alain, Goetz, Morgan, Findlay, Ingrid A., Mercer‐Smith, Alison, Kass, Lauren E., Khagi, Simon, Hingtgen, Shawn D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115686/ https://www.ncbi.nlm.nih.gov/pubmed/35600639 http://dx.doi.org/10.1002/btm2.10283 |
Ejemplares similares
-
Personalized‐induced neural stem cell therapy: Generation, transplant, and safety in a large animal model
por: Bomba, Hunter N., et al.
Publicado: (2020) -
THER-15. DEVELOPING TUMOR-HOMING CYTOTOXIC HUMAN INDUCED NEURAL STEM CELL THERAPY FOR BRAIN METASTASES
por: Mercer-Smith, Alison, et al.
Publicado: (2019) -
56. TUMOR-HOMING STEM CELL THERAPY INHIBITS THE PROGRESSION OF BREAST CANCER LEPTOMENINGEAL CARCINOMATOSIS
por: Jiang, Wulin, et al.
Publicado: (2020) -
Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection
por: Okolie, Onyinyechukwu, et al.
Publicado: (2018) -
Floseal-induced small bowel obstruction
por: Ashraf, Hamza, et al.
Publicado: (2022)